Chemical Compound

2-Amino-N~1~,N~9~-bis(6S,9R,10S,13R,18aS){13-[(2S)-butan-2-yl]-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6-(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl}-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

CAS Registry Number 6156-47-4
2-Amino-N~1~,N~9~-bis(6S,9R,10S,13R,18aS){13-[(2S)-butan-2-yl]-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6-(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl}-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide 结构式
Primary record

2-Amino-N~1~,N~9~-bis(6S,9R,10S,13R,18aS){13-[(2S)-butan-2-yl]-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6-(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl}-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

库存
4,983 克
纯度
99.5 %
CAS
6156-47-4

化合物标识与属性

CAS
6156-47-4
PubChem CID
20055431
SMILES
CC[C@H](C)[C@@H]1C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)[C@@H](C)CC)C)C)C(C)C)C)N)C)C)C(C)C)C)C
Canonical SMILES
CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)c2c3nc4c(C(=O)N[C@@H]5C(=O)N[C@H]([C@@H](C)CC)C(=O)N6CCC[C@H]6C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]5C)ccc(C)c4oc-3c(C)c(=O)c2N)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C1=O

名称与同义词

  • Actinomycin C3
  • Actinomycin vii
  • Actinomycin I3
  • Actinomycin AY1
  • Aurathin-A3
  • RefChem:109522
  • 6Z5DS38J6F
  • UNII-6Z5DS38J6F
  • AY 3
  • NSC-87222
  • DTXSID30873421
  • SCHEMBL29886449
  • NSC 87222
  • 2104-L-I
  • DTXCID601011711
  • NSC87221
  • C64H90N12O16
  • 6156-47-4
  • C64-H90-N12-O16
  • J846.911C
  • NS00011849
  • 2A-D-Alloisoleucine-2B-D-alloisoleucine actinomycino-D
  • Actinomycin D, 2A-D-alloisoleucine-2B-D-alloisoleucine-
  • Q27265752
  • 2-amino-1-N,9-N-bis(3-butan-2-yl-7,11,14-trimethyl-2,5,9,12,
  • Actinomycin D, 2(sup A)-D-alloisoleucine-2(sup B)-D-alloisoleucine-
  • 2-amino-1-N,9-N-bis[(3R,6S,7R,10S,16S)-3-[(2S)-butan-2-yl]-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-10-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboxamide
  • 2-Amino-N~1~,N~9~-bis(6S,9R,10S,13R,18aS){13-[(2S)-butan-2-yl]-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6-(propan-2-yl)hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl}-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide
  • 3H-PHENOXAZINE-1,9-DICARBOXAMIDE, 2-AMINO-N,N'-BIS(HEXADECAHYDRO-2,5,9-TRIMETHYL-6-(1-METHYLETHYL)-13-(1-METHYLPROPYL)-1,4,7,11,14-PENTAOXO-1H-PYRROLO(2,1-I)(1,4,7,10,13)OXATETRAAZACYCLOHEXADECIN-10-YL)-4,6-DIMETHYL-3-OXO-
  • N,N -[(2-Amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonyl)]bis[cyclo(L-Thr*-D-aIle-L-Pro-Sar-N-methyl-L-Val-)]
  • N1,N9-bis[(6S,9R,10S,13R,18aS)-13-[(2S)-butan-2-yl]-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6-(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide